Sociodemographic profile and comorbidities of older adults with tuberculosis attended at the General Hospital of Coronel Oviedo, Paraguay (2024)
DOI:
https://doi.org/10.5281/zenodo.22164973Keywords:
tuberculosis, aged, comorbidity, mental disorders, Paraguay, retrospective studiesAbstract
Introduction: Tuberculosis disproportionately affects older adults, with reactivation of latent infection and often late diagnosis; local information on this group is scarce in Paraguay. The aim was to describe the sociodemographic profile and comorbidities of older adults with tuberculosis attended at the General Hospital of Coronel Oviedo during 2024. Materials and methods: Retrospective descriptive observational study. Records of the National Tuberculosis Control Program at the hospital were reviewed and patients aged 60 years or older with tuberculosis in 2024 were identified, analyzing age, sex, residence, schooling, occupation, comorbidities and treatment phase with descriptive statistics. Results: Of 243 persons on antituberculosis treatment in 2024, 31 new cases were diagnosed in the second half of the year, 8 (25.8%) in older adults. Seven were men; mean age was 73.6 years (range 63-94). Six lived in urban areas and 4 worked in agriculture. Six (75.0%) had at least one comorbidity; the most frequent was psychiatric disorder (3 cases), followed by diabetes, hypertension and substance use (one case each). Five were in the intensive phase. Conclusions: Older adults accounted for one quarter of new cases in the semester, mostly men with comorbidities, especially mental health disorders. Despite the small number of cases, the findings support active case finding in older age, integration with mental health services and accompaniment to sustain adherence.References
World Health Organization. Global tuberculosis report 2024. Geneva: World Health Organization; 2024.
Lawn SD, Zumla AI. Tuberculosis. Lancet. 2011;378(9785):57-72. https://doi.org/10.1016/S0140-6736(10)62173-3
Caraux-Paz P, Diamantis S, de Wazières B, Gallien S. Tuberculosis in the elderly. J Clin Med. 2021;10(24):5888. https://doi.org/10.3390/jcm10245888
Rajagopalan S. Tuberculosis and aging: a global health problem. Clin Infect Dis. 2001;33(7):1034-9. https://doi.org/10.1086/322671
Piergallini TJ, Turner J. Tuberculosis in the elderly: why inflammation matters. Exp Gerontol. 2018;105:32-9. https://doi.org/10.1016/j.exger.2017.12.021
Cantalice Filho JP, Sant'Anna CC, Bóia MN. Aspectos clínicos da tuberculose pulmonar em idosos atendidos em hospital universitário do Rio de Janeiro, RJ, Brasil. J Bras Pneumol. 2007;33(6):699-706. https://doi.org/10.1590/S1806-37132007000600014
Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363(11):1005-15. https://doi.org/10.1056/NEJMoa0907847
Pan American Health Organization. Tuberculosis in the Americas, 2023. Washington, DC: Pan American Health Organization; 2023.
Ministerio de Salud Pública y Bienestar Social, Programa Nacional de Control de la Tuberculosis. Informe epidemiológico de tuberculosis, Paraguay, 2023. Asunción: MSPBS; 2023.
Kwon YS, Chi SY, Oh IJ, Kim KS, Kim YI, Lim SC, et al. Clinical characteristics and treatment outcomes of tuberculosis in the elderly: a case control study. BMC Infect Dis. 2013;13:121. https://doi.org/10.1186/1471-2334-13-121
Jhaveri TA, Jhaveri D, Galivanche A, Lubeck-Schricker M, Voehler D, Chung M, et al. Barriers to engagement in the care cascade for tuberculosis disease in India: a systematic review of quantitative studies. PLoS Med. 2024;21(5):e1004409. https://doi.org/10.1371/journal.pmed.1004409
Maciel EL, Reis-Santos B. Determinants of tuberculosis in Brazil: from conceptual framework to practical application. Rev Panam Salud Publica. 2015;38(1):28-34.
Hayashi S, Chandramohan D. Risk of active tuberculosis among people with diabetes mellitus: systematic review and meta-analysis. Trop Med Int Health. 2018;23(10):1058-70. https://doi.org/10.1111/tmi.13133
Ruiz-Grosso P, Cachay R, de la Flor A, Schwalb A, Ugarte-Gil C. Association between tuberculosis and depression on negative outcomes of tuberculosis treatment: a systematic review and meta-analysis. PLoS One. 2020;15(1):e0227472. https://doi.org/10.1371/journal.pone.0227472
Imtiaz S, Shield KD, Roerecke M, Samokhvalov AV, Lönnroth K, Rehm J. Alcohol consumption as a risk factor for tuberculosis: meta-analyses and burden of disease. Eur Respir J. 2017;50(1):1700216. https://doi.org/10.1183/13993003.00216-2017
Bhargava A, Bhargava M, Meher A, Benedetti A, Velayutham B, Sai Teja G, et al. Nutritional supplementation to prevent tuberculosis incidence in household contacts of patients with pulmonary tuberculosis in India (RATIONS): a field-based, open-label, cluster-randomised, controlled trial. Lancet. 2023;402(10402):627-40. https://doi.org/10.1016/S0140-6736(23)01231-X
Karumbi J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2015;(5):CD003343. https://doi.org/10.1002/14651858.CD003343.pub4
Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006;174(8):935-52. https://doi.org/10.1164/rccm.200510-1666ST
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Keilane Costa Cavanhol, Sérgio Tadeu Gomes de Morais, Antônio dos Santos Baptista, Diógenes Durañones (Autor/a)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles are distributed under the Creative Commons Attribution 4.0 International — CC BY 4.0 licence. Authors retain copyright and grant the journal the right of first publication. Any reuse must acknowledge authorship, cite the original source and indicate whether changes were made.











